Nuvation Bio Statistics
Share Statistics
Nuvation Bio has 339.26M
shares outstanding. The number of shares has increased by 36.62%
in one year.
| Shares Outstanding | 339.26M |
| Shares Change (YoY) | 36.62% |
| Shares Change (QoQ) | 0.33% |
| Owned by Institutions (%) | 72.27% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 43,116 |
| FTD / Avg. Volume | 1.29% |
Short Selling Information
The latest short interest is 33.1M, so 9.77% of the outstanding
shares have been sold short.
| Short Interest | 33.1M |
| Short % of Shares Out | 9.77% |
| Short % of Float | 13.68% |
| Short Ratio (days to cover) | 11.84 |
Valuation Ratios
The PE ratio is -1.26 and the forward
PE ratio is -3.42.
Nuvation Bio's PEG ratio is
0.
| PE Ratio | -1.26 |
| Forward PE | -3.42 |
| PS Ratio | 90.81 |
| Forward PS | 1.9 |
| PB Ratio | 1.54 |
| P/FCF Ratio | -5.48 |
| PEG Ratio | 0 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Nuvation Bio.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.04,
with a Debt / Equity ratio of 0.02.
| Current Ratio | 9.04 |
| Quick Ratio | 9.04 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | -0.02 |
| Debt / FCF | -0.07 |
| Interest Coverage | -1737.91 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $28,838.83 |
| Profits Per Employee | $-2,080,362.64 |
| Employee Count | 273 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -34.24% in the
last 52 weeks. The beta is 1.42, so Nuvation Bio's
price volatility has been higher than the market average.
| Beta | 1.42 |
| 52-Week Price Change | -34.24% |
| 50-Day Moving Average | 2.01 |
| 200-Day Moving Average | 2.48 |
| Relative Strength Index (RSI) | 53.93 |
| Average Volume (20 Days) | 3,340,933 |
Income Statement
In the last 12 months, Nuvation Bio had revenue of 7.87M
and earned -567.94M
in profits. Earnings per share was -2.11.
| Revenue | 7.87M |
| Gross Profit | 795K |
| Operating Income | -592.63M |
| Net Income | -567.94M |
| EBITDA | -566.91M |
| EBIT | -567.6M |
| Earnings Per Share (EPS) | -2.11 |
Full Income StatementBalance Sheet
The company has 35.72M in cash and 8.91M in
debt, giving a net cash position of 26.81M.
| Cash & Cash Equivalents | 35.72M |
| Total Debt | 8.91M |
| Net Cash | 26.81M |
| Retained Earnings | -910.74M |
| Total Assets | 540.63M |
| Working Capital | 468.01M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -130.41M
and capital expenditures -162K, giving a free cash flow of -130.57M.
| Operating Cash Flow | -130.41M |
| Capital Expenditures | -162K |
| Free Cash Flow | -130.57M |
| FCF Per Share | -0.49 |
Full Cash Flow StatementMargins
Gross margin is 10.1%, with operating and profit margins of -7527.33% and -7213.76%.
| Gross Margin | 10.1% |
| Operating Margin | -7527.33% |
| Pretax Margin | -7213.76% |
| Profit Margin | -7213.76% |
| EBITDA Margin | -7200.75% |
| EBIT Margin | -7527.33% |
| FCF Margin | -1658.52% |
